(HealthDay)—Two protein markers may serve as biomarkers for chronic rhinosinusitis, according to a proof-of-principle study published in The Laryngoscope.
Oct 27, 2014
not rated yet | 0
Swiss pharmaceutical group Roche hopes to obtain fast-track US approval for a rapid diagnostic test for Ebola, its director general said in an interview published Sunday, amid the worst-ever outbreak of the killer disease.
Oct 26, 2014
5 / 5 (1) | 0